Celltrion Q2 net profit drops 48%
Celltrion Inc., a South Korean biopharmaceutical company, said Wednesday its second-quarter net profit plunged 48 percent from a year earlier due to costs following a merger with its sales and…
Celltrion Inc., a South Korean biopharmaceutical company, said Wednesday its second-quarter net profit plunged 48 percent from a year earlier due to costs following a merger with its sales and…